Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
PaperCitations, authors & open-access status
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 277 citations, 2020 year and green oa status.
277
Citations
2020
Year
green
OA Status